Resumption of warfarin therapy after gastrointestinal tract bleeding: benefit or bias?
- PMID: 23700015
- DOI: 10.1001/jamainternmed.2013.3763
Resumption of warfarin therapy after gastrointestinal tract bleeding: benefit or bias?
Comment in
-
Resumption of warfarin therapy after gastrointestinal tract bleeding: benefit or bias?--Reply.JAMA Intern Med. 2013 May 13;173(9):832-3. doi: 10.1001/jamainternmed.2013.14. JAMA Intern Med. 2013. PMID: 23700016 No abstract available.
Comment on
-
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.Arch Intern Med. 2012 Oct 22;172(19):1484-91. doi: 10.1001/archinternmed.2012.4261. Arch Intern Med. 2012. PMID: 22987143
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical